Jani AB - Search Results

1

Feasibility of accelerated partial breast irradiation in a large inner-city public hospital.

Amin M, Gabram S, Bumpers H, Landry J, Jani AB, Diaz R, Rizzo M. Amin M, et al. Among authors: jani ab. Ann Surg Oncol. 2012 Dec;19(13):4094-8. doi: 10.1245/s10434-012-2444-x. Epub 2012 Jun 26. Ann Surg Oncol. 2012. PMID: 22732836

2

Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.

Jani AB, Johnstone PA, Liauw SL, Master VA, Rossi PJ. Jani AB, et al. Am J Clin Oncol. 2010 Apr;33(2):168-72. doi: 10.1097/COC.0b013e3181a44ebe. Am J Clin Oncol. 2010. PMID: 19745696

3

Lymphadenectomy for patients with cervical cancer: is it of value?

Rossi PJ, Horowitz IR, Johnstone PA, Jani AB. Rossi PJ, et al. Among authors: jani ab. J Surg Oncol. 2009 Oct 1;100(5):404-6. doi: 10.1002/jso.21330. J Surg Oncol. 2009. PMID: 19760670

4

A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.

Terakedis BE, Rossi PJ, Liauw SL, Johnstone PA, Jani AB. Terakedis BE, et al. Among authors: jani ab. Am J Clin Oncol. 2010 Dec;33(6):619-23. doi: 10.1097/COC.0b013e3181c4c6e1. Am J Clin Oncol. 2010. PMID: 20051808

5

Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients.

Kahn S, Jani A, Edelman S, Rossi P, Godette K, Landry J, Anderson C. Kahn S, et al. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):16-21. doi: 10.1016/j.ijrobp.2011.05.047. Epub 2011 Nov 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22104362

6

Therapeutic options for a rising PSA after radical prostatectomy.

Carthon BC, Marcus DM, Herrel LA, Jani AB, Rossi PJ, Canter DJ. Carthon BC, et al. Among authors: jani ab. Can J Urol. 2013 Jun;20(3):6748-55. Can J Urol. 2013. PMID: 23783041 Free article. Review.

7

Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.

Rossi PJ, Jani AB, Horowitz IR, Johnstone PA. Rossi PJ, et al. Among authors: jani ab. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):134-8. doi: 10.1016/j.ijrobp.2007.05.048. Epub 2007 Sep 12. Int J Radiat Oncol Biol Phys. 2008. PMID: 17855014

8

Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.

Jani AB, Johnstone PA, Liauw SL, Master VA, Brawley OW. Jani AB, et al. Am J Clin Oncol. 2008 Aug;31(4):375-8. doi: 10.1097/COC.0b013e3181637384. Am J Clin Oncol. 2008. PMID: 18845997

9

Toxicity analysis of dose escalation from 75.6 gy to 81.0 gy in prostate cancer.

Xu N, Rossi PJ, Jani AB. Xu N, et al. Among authors: jani ab. Am J Clin Oncol. 2011 Feb;34(1):11-5. doi: 10.1097/COC.0b013e3181cae8c6. Am J Clin Oncol. 2011. PMID: 20101167

10

Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease.

Hsiao W, Moses KA, Goodman M, Jani AB, Rossi PJ, Master VA. Hsiao W, et al. Among authors: jani ab. J Urol. 2010 Aug;184(2):512-8. doi: 10.1016/j.juro.2010.04.010. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters